Cargando…
Design, Synthesis and Biological Evaluation of Novel PEG-Rakicidin B1 Hybrid as Clostridium difficile (CD) Targeted Anti-Bacterial Agent
Rakicidin B1 was isolated and purified from the culture broth of a marine Streptomyces sp. as a potent anti-cancer agent, and lately the compound and its derivatives have firstly been found to possess anti-Clostridium difficile (CD) activity but with high cytotoxicity. Herein, following our previous...
Autores principales: | Xie, Lijun, Chen, Li, Wei, Yongbo, Chen, Nannan, Wu, Tong, Zhou, Jingming, Jiang, Hong, Lin, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457740/ https://www.ncbi.nlm.nih.gov/pubmed/37630404 http://dx.doi.org/10.3390/molecules28166152 |
Ejemplares similares
-
Application of Lithiation–Borylation to the
Total Synthesis of (−)-Rakicidin F
por: Bold, Christian P., et al.
Publicado: (2022) -
Draft genome sequence of Streptomyces sp. MWW064 for elucidating the rakicidin biosynthetic pathway
por: Komaki, Hisayuki, et al.
Publicado: (2016) -
Clostridium difficile Is an Autotrophic Bacterial Pathogen
por: Köpke, Michael, et al.
Publicado: (2013) -
Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection
por: Zhanel, George G, et al.
Publicado: (2015) -
Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)